Building a better sphingosine kinase-1 inhibitor

Biochemical Journal

Volumn 444, Issue 1, 2012, Pages

  Lynch, Kevin R ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Fingolimod (FTY720); PF 543; Sphingolipid rheostat; Sphingosine 1 phosphate (S1P); Sphingosine kinase 1

Indexed keywords

FINGOLIMOD; PF 543; PHOSPHOTRANSFERASE INHIBITOR; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 1 INHIBITOR; SPHINGOSINE KINASE 2; UNCLASSIFIED DRUG;

BIOSYNTHESIS; CANCER GROWTH; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROSIS; HUMAN; IC 50; IMMUNOMODULATION; INFLAMMATION; LYMPHOCYTE MIGRATION; MOLECULAR BIOLOGY; MULTIPLE SCLEROSIS; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

HUMANS; LYSOPHOSPHOLIPIDS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PYRROLIDINES; SPHINGOSINE; SULFONES;

EID: 84860810481     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20120567     Document Type: Note

References (10)

1. Brinkmann, V. (2009) FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system. Br. J. Pharmacol. 158, 1173-1182
2. Kohama, T., Olivera, A., Edsall, L., Nagiec, M. M., Dickson, R. and Spiegel, S. (1998) Molecular cloning and functional characterization of mammalian sphingosine kinase. J. Biol. Chem. 273, 23772-23728
3. Liu, H., Sugiura, M., Nava, V. E., Edsall, L. C., Kono, K., Poulton, S., Milstien, S., Kohama, T. and Spiegel, S. (2000) Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J. Biol. Chem. 275, 19513-19520 (Pubitemid 30441543)
4. Mizugishi, K., Yamashita, T., Olivera, A., Miller, G. F., Spiegel, S. and Proia, R. L. (2005) Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Biol. 25, 11113-11121 (Pubitemid 41747151)
5. Kharel, Y., Lee, S., Snyder, A. H., Sheasley-O'Neill, S. L., Morris, M. A., Setiady, Y., Zhu, R., Zigler, M. A., Burcin, T. L., Ley, K. et al. (2005) Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J. Biol. Chem. 280, 36865-36872 (Pubitemid 41587768)
6. Zemann, B., Kinzel, B., Müller, M., Reuschel, R., Mechtcheriakova, D., Urtz, N., Bornacin, R., Baumruker, T. and Billich, A. (2006) Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood 107, 1454-1458 (Pubitemid 43242381)
7. Van Brocklyn, J. R., Jackson, C. A., Pearl, D. K., Kotur, M. S., Snyder, P. J. and Prior, T. W. (2005) Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J. Neuropathol. Exp. Neurol. 64, 695-705 (Pubitemid 41177111)
8. Schnute, M. E., McReynolds, M. D., Kasten, T., Yates, M., Jerome, G., Rains, J. W., Hall, T., Chrencik, J., Kraus, M., Cronin, C. N. et al. (2012) Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1. Biochem. J. 444, 79-88
9. Kharel, Y., Mathews, T. P., Gellett, A. M., Tomsig, J. L., Kennedy, P. C., Moyer, M. L., Macdonald, T. L. and Lynch, K. R. (2011) Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate. Biochem. J. 440, 345-353
10. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, J. S. and Spiegel, S. (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381, 800-803 (Pubitemid 26243122)